MindBio Therapeutics obtained approvals for clinical trials in women’s health using its proprietary LSD drug, MB22001. MB22001 aims to address a huge unmet need in the ~25% of women who experience PMS ...
In a recent study published in the journal Translational Psychiatry, researchers from New Zealand conducted a phase I trial to assess the effect of micro-dosing of lysergic acid diethylamide (LSD) on ...
According to Amanda Feilding, one tenth of what's considered a full dose of LSD is enough to make her feel "sparkly." As the founder and director of the UK-based nonprofit Beckley Foundation, Feilding ...
Psychedelics have entered the mainstream in a big way: Investors have staked billions on potential medical treatments, scientific research has skyrocketed and public sentiment signals growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback